Cell‐Derived Vesicles for Antibiotic Delivery—Understanding the Challenges of a Biogenic Carrier System
Open Access
Abstract
Recently, extracellular vesicles (EVs) sparked substantial therapeutic interest, particularly due to their ability to mediate targeted transport between tissues and cells. Yet, EVs’ technological translation as therapeutics strongly depends on better biocompatibility assessments in more complex models and elementary in vitro–in vivo correlation, and comparison of mammalian versus bacterial vesicles. With this in mind, two new types of EVs derived from human B‐lymphoid cells with low immunogenicity and from non‐pathogenic myxobacteria SBSr073 are introduced here. A large‐scale isolation protocol to reduce plastic waste and cultivation space toward sustainable EV research is established. The biocompatibility of mammalian and bacterial EVs is comprehensively evaluated using cytokine release and endotoxin assays in vitro, and an in vivo zebrafish larvae model is applied. A complex three‐dimensional human cell culture model is used to understand the spatial distribution of vesicles in epithelial and immune cells and again used zebrafish larvae to study the biodistribution in vivo. Finally, vesicles are successfully loaded with the fluoroquinolone ciprofloxacin (CPX) and showed lower toxicity in zebrafish larvae than free CPX. The loaded vesicles are then tested effectively on enteropathogenic Shigella, whose infections are currently showing increasing resistance against available antibiotics.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (13XP5029A)
- European Research Council (945602)
This publication has 71 references indexed in Scilit:
- The Zebrafish as a New Model for the In Vivo Study of Shigella flexneri Interaction with Phagocytes and Bacterial AutophagyPLOS Pathogens, 2013
- Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe–America and Asia–Africa from 1998 to 2009International Journal of Antimicrobial Agents, 2012
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant eraJournal of Controlled Release, 2011
- Characterization of Translocation of Silver Nanoparticles and Effects on Whole-Genome Gene Expression Using an In Vitro Intestinal Epithelium Coculture ModelACS Nano, 2011
- A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in ExosomesMolecular Therapy, 2010
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- Cytokines, Inflammation, and PainInternational Anesthesiology Clinics, 2007
- Regulation of Genes for HLA Class II Antigens in Cell Lines from Patients with Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1988
- Immunomodulation by Myxospores of Myxococcus xanthusMicrobiology, 1985